ATE101140T1 - Substituierte cycloalkanole. - Google Patents
Substituierte cycloalkanole.Info
- Publication number
- ATE101140T1 ATE101140T1 AT88308565T AT88308565T ATE101140T1 AT E101140 T1 ATE101140 T1 AT E101140T1 AT 88308565 T AT88308565 T AT 88308565T AT 88308565 T AT88308565 T AT 88308565T AT E101140 T1 ATE101140 T1 AT E101140T1
- Authority
- AT
- Austria
- Prior art keywords
- halo
- integers
- alkyl
- hydrogen
- cycloalcanols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/102,695 US4826844A (en) | 1987-09-30 | 1987-09-30 | Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols |
| EP88308565A EP0310268B1 (de) | 1987-09-30 | 1988-09-16 | Substituierte Cycloalkanole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE101140T1 true ATE101140T1 (de) | 1994-02-15 |
Family
ID=22291200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88308565T ATE101140T1 (de) | 1987-09-30 | 1988-09-16 | Substituierte cycloalkanole. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4826844A (de) |
| EP (1) | EP0310268B1 (de) |
| JP (1) | JPH01121281A (de) |
| KR (1) | KR890005069A (de) |
| AT (1) | ATE101140T1 (de) |
| AU (1) | AU617117B2 (de) |
| CA (1) | CA1301757C (de) |
| DE (1) | DE3887614T2 (de) |
| ES (1) | ES2061670T3 (de) |
| GB (1) | GB2210366B (de) |
| IE (1) | IE60916B1 (de) |
| ZA (1) | ZA886798B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506270A (en) * | 1995-01-30 | 1996-04-09 | American Home Products Corporation | Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| SE9504662D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9904674D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904673D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE0001209D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| MXPA03010445A (es) | 2001-05-18 | 2004-03-09 | Astrazeneca Ab | Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales. |
| DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
| CA2470808A1 (en) * | 2001-12-21 | 2003-07-03 | Taisho Pharmaceutical Co., Ltd. | Piperazine derivative |
| US20040152710A1 (en) * | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US7345096B2 (en) * | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US20040180879A1 (en) * | 2002-10-15 | 2004-09-16 | Deecher Darlene Coleman | Novel method of treating vasomotor symptoms |
| SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203302D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| US7531543B2 (en) * | 2003-10-14 | 2009-05-12 | Wyeth | Phenylpiperazine cycloalkanol derivatives and methods of their use |
| US7419980B2 (en) * | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
| US7491723B2 (en) * | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
| US7550485B2 (en) * | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
| US7524846B2 (en) * | 2003-10-14 | 2009-04-28 | Wyeth | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| US7402698B2 (en) * | 2003-10-14 | 2008-07-22 | Wyeth | Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use |
| US7365076B2 (en) * | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
| US20050130987A1 (en) * | 2003-10-14 | 2005-06-16 | Wyeth | Methods of treating vasomotor symptoms |
| US20050207983A1 (en) * | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
| US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7414052B2 (en) * | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| DK1781631T3 (da) | 2004-08-02 | 2012-05-14 | Astrazeneca Ab | Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH351273A (fr) * | 1954-11-12 | 1961-01-15 | Abbott Lab | Procédé de préparation de sels d'ammonium quaternaire |
| US2971955A (en) * | 1958-12-29 | 1961-02-14 | Abbott Lab | Cyclohexylcarbinol derivatives of piperazine |
| US4163849A (en) * | 1978-03-17 | 1979-08-07 | Merck & Co., Inc. | Piperazinylpyrazines |
| US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| FR2559765B1 (fr) * | 1984-02-16 | 1986-06-13 | Rhone Poulenc Sante | Nouveaux derives de la phenyl-3 propene-2 amine, leur preparation et les medicaments qui les contiennent |
| US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
| US4745191A (en) * | 1987-09-30 | 1988-05-17 | American Home Products Corporation | 1-((A-substituted phenyl-ω-substituted piperazinyl)alkenyl) cyclohexanol |
-
1987
- 1987-09-30 US US07/102,695 patent/US4826844A/en not_active Expired - Lifetime
-
1988
- 1988-09-07 IE IE271088A patent/IE60916B1/en not_active IP Right Cessation
- 1988-09-12 ZA ZA886798A patent/ZA886798B/xx unknown
- 1988-09-13 AU AU22155/88A patent/AU617117B2/en not_active Ceased
- 1988-09-16 DE DE88308565T patent/DE3887614T2/de not_active Expired - Fee Related
- 1988-09-16 AT AT88308565T patent/ATE101140T1/de not_active IP Right Cessation
- 1988-09-16 ES ES88308565T patent/ES2061670T3/es not_active Expired - Lifetime
- 1988-09-16 EP EP88308565A patent/EP0310268B1/de not_active Expired - Lifetime
- 1988-09-16 GB GB8821758A patent/GB2210366B/en not_active Expired - Fee Related
- 1988-09-28 KR KR1019880012512A patent/KR890005069A/ko not_active Application Discontinuation
- 1988-09-28 CA CA000578905A patent/CA1301757C/en not_active Expired - Fee Related
- 1988-09-29 JP JP63245833A patent/JPH01121281A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3887614D1 (de) | 1994-03-17 |
| IE60916B1 (en) | 1994-08-24 |
| GB8821758D0 (en) | 1988-10-19 |
| EP0310268A2 (de) | 1989-04-05 |
| CA1301757C (en) | 1992-05-26 |
| US4826844A (en) | 1989-05-02 |
| JPH01121281A (ja) | 1989-05-12 |
| ZA886798B (en) | 1990-05-30 |
| AU2215588A (en) | 1989-04-06 |
| IE882710L (en) | 1989-03-30 |
| DE3887614T2 (de) | 1994-05-11 |
| GB2210366B (en) | 1991-05-29 |
| EP0310268B1 (de) | 1994-02-02 |
| GB2210366A (en) | 1989-06-07 |
| EP0310268A3 (en) | 1990-05-23 |
| ES2061670T3 (es) | 1994-12-16 |
| KR890005069A (ko) | 1989-04-11 |
| AU617117B2 (en) | 1991-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2061670T3 (es) | Cicloalcanoles substituidos. | |
| PL292101A1 (en) | Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine | |
| GR3036455T3 (en) | Atherosclerosis treatment | |
| SG47986A1 (en) | A pharmaceutical solution | |
| ES8604128A1 (es) | Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida | |
| HUT45984A (en) | Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts | |
| GR3005990T3 (de) | ||
| IL118368A0 (en) | N-oxide heteroaroyl derivatives | |
| HUT48209A (en) | Process for producing heterocyclic oxo compounds comprising substituted amino group and having antiallergic and antiinflammatory action | |
| NZ326675A (en) | Oxazoline arthropodicides | |
| FI875145A0 (fi) | Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner. | |
| GB8706662D0 (en) | Anti-arrhythmia agents | |
| DE3572814D1 (en) | 1, 3-benzoxathiole derivatives, their use and their preparation | |
| FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
| MX9302303A (es) | Derivados monocuaternarioos de 2,16-bispiperidinilandrostano. | |
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| GR3004095T3 (de) | ||
| IL75430A0 (en) | Pineapple ketone carbonate derivatives and their use as flavoring agents | |
| ES2093051T3 (es) | Purinil- y pirimidil-tetrahidrofuranos. | |
| ES2004215A6 (es) | Procedimiento para preparar quinazolinas tetraciclicas | |
| DE3867494D1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| FI941850A0 (fi) | Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö | |
| LU88449I2 (fr) | Fleroxacine et ses dérivés pharmaceutiquement acceptables. | |
| GB8600879D0 (en) | Pregnane derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |